Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Sarcoma 9Rhabdomyosarcoma 5Wilms Tumor 2Ovarian Neoplasms 2Melanoma 2Malignant mesenchymal tumor 2Gestational Trophoblastic Disease 2Fibrosarcoma 2Testicular Neoplasms 1Teratoma, Ovarian 1Sarcoma, Alveolar Soft Part 1Rhabdoid Tumor 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms, Germ Cell and Embryonal 1Liposarcoma 1Kidney Neoplasms 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Desmoplastic Small Round Cell Tumor 1Dermatofibrosarcoma 1Chondrosarcoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Magnetic Resonance Spectroscopy 7X-Rays 6Phantoms, Imaging 6Cyclophosphamide 6Specimen Handling 5Nuclear Medicine Department, Hospital 5Topotecan 4Etoposide 4Biopsy 4palbociclib 3Vincristine 3Methotrexate 3Cisplatin 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2olaparib 2larotrectinib 2ivosidenib 2etoposide phosphate 2erdafitinib 2ensartinib 2Vemurafenib 2Temozolomide 2Radiotherapy 2Nivolumab 2LY3023414 2Carboplatin 2selinexor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Rhabdoid Tumor × Dactinomycin × Clear all
NCT00084838 2015-12-24

Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT

Dana-Farber Cancer Institute

Phase 2 Completed
25 enrolled 24 charts
CNS

Central Nervous System Neoplasms, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡